{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:06:58Z","timestamp":1777460818618,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,7,1]],"date-time":"1998-07-01T00:00:00Z","timestamp":899251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,7,1]],"date-time":"1998-07-01T00:00:00Z","timestamp":899251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[1998,7]]},"DOI":"10.1124\/mol.54.1.139","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T20:30:44Z","timestamp":1515443444000},"page":"139-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Identification of a [3H]Ligand for the Common Allosteric Site of Muscarinic Acetylcholine M2 Receptors"],"prefix":"10.1016","volume":"54","author":[{"given":"Christian","family":"Tr\u00e4nkle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Mies-Klomfass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario H. Botero","family":"Cid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Holzgrabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.54.1.139_bib1","series-title":"Neurotransmitter Receptor Binding","first-page":"84","article-title":"Neurotransmitter, hormone, or drug receptor binding methods","author":"Bennett","year":"1985"},{"key":"10.1124\/mol.54.1.139_bib2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0024-3205(97)00046-5","article-title":"Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes.","volume":"60","author":"Birdsall","year":"1997","journal-title":"Life Sci"},{"key":"10.1124\/mol.54.1.139_bib3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0026-895X(25)09591-4","article-title":"Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.","volume":"38","author":"Bruns","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib4","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-6147(89)90266-6","article-title":"Calculating receptor number from binding experiments using same compound as radioligand and competitor.","volume":"10","author":"DeBlasi","year":"1989","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.54.1.139_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0026-895X(25)13145-3","article-title":"Estimation ot the affinities of allosteric ligands using radioligand binding and pharmacological null methods.","volume":"35","author":"Ehlert","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0026-895X(25)09006-6","article-title":"Two allosteric modulators interact at a common site on cardiac muscarinic receptors.","volume":"42","author":"Ellis","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib8","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/0006-2952(89)90093-2","article-title":"Comparison between the activities of cationic amphiphilic drugs to affect phospholipid-membranes and to depress cardiac function.","volume":"15","author":"Girke","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib9","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0026-895X(25)09558-6","article-title":"Regulation of D2 dopamine receptors by amiloride and amiloride analogs.","volume":"50","author":"Hoare","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/ci9502515","article-title":"Conformational analysis, molecular shape comparison, and pharmacophore identification of different allosteric modulators of muscarinic receptors.","volume":"36","author":"Holzgrabe","year":"1996","journal-title":"J Chem Inf Comput Sci"},{"key":"10.1124\/mol.54.1.139_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0263-7855(96)00060-4","article-title":"Comparison of structurally different allosteric modulators of muscarinic receptors by self-organizing neural networks.","volume":"14","author":"Holzgrabe","year":"1996","journal-title":"J Mol Graph"},{"key":"10.1124\/mol.54.1.139_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1124\/mol.52.1.172","article-title":"Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.","volume":"52","author":"Jakub\u0131\u0301k","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0165-6147(97)88188-6","article-title":"Quantitation of allosteric interactions.","volume":"17","author":"Kostenis","year":"1996","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.54.1.139_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0022-3565(24)36766-7","article-title":"Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.","volume":"282","author":"Lanzafame","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.54.1.139_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0026-895X(25)10255-1","article-title":"Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.","volume":"48","author":"Lazareno","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1476-5381.1993.tb13737.x","article-title":"Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations.","volume":"109","author":"Lazareno","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-2952(91)90703-8","article-title":"Allosteric antagonists of the muscarinc acetylcholine receptor.","volume":"42","author":"Lee","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0005-2736(84)90496-6","article-title":"Adsorption of local anesthetics on phospholipid membranes.","volume":"777","author":"Ohki","year":"1984","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.54.1.139_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF00549444","article-title":"Effects and mechanisms of action of alkane-bis-ammonium derivatives in organophosphate poisoning.","volume":"263","author":"Ohnesorge","year":"1969","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib20","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0026-895X(25)10523-3","article-title":"Competition between positive and negative allosteric effectors on muscarinic receptors.","volume":"48","author":"Pro\u0161ka","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0006-2952(83)90579-8","article-title":"Drug-induced surface potential changes of lipid vesicles and the role of calcium.","volume":"32","author":"Schlieper","year":"1983","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/mol.53.2.304","article-title":"M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.","volume":"53","author":"Tr\u00e4nkle","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(25)21206-X","article-title":"Search for lead structures to develop new allosteric modulators of muscarinic receptors.","volume":"279","author":"Tr\u00e4nkle","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.54.1.139_bib24","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1124\/mol.51.4.674","article-title":"Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.","volume":"51","author":"Tr\u00e4nkle","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.54.1.139_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-6147(00)89023-9","article-title":"Allosteric modulation of muscarinic acetylcholine receptors.","volume":"16","author":"Tuc\u0306ek","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.54.1.139_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0026-895X(25)08892-3","article-title":"Novel amiloride analog allosterically modulates the \u03b12-adrenergic receptor but does not inhibit Na+\/H+ exchange.","volume":"42","author":"Wilson","year":"1992","journal-title":"Mol Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24131367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24131367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.54.1.139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:59:43Z","timestamp":1740045583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24131367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["S0026895X24131367"],"URL":"https:\/\/doi.org\/10.1124\/mol.54.1.139","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[1998,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a [3H]Ligand for the Common Allosteric Site of Muscarinic Acetylcholine M2 Receptors","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.54.1.139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 1998 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}